AR AR6- 3233 405 _-- - TRADE SECRET Study Title H9-02-47D6a8y:GaSvuabgcehrSotnuidcyTionxRiactisty with One-Generation Reproduction Evaluations Volume 5 of 5 Laboratory Project ID: DuPont-5990 HRaze - 2225 oDwupoe5s590 TEST GUIDELINES: OU.PS.PTESP8A70He.a3l1t0h0E(f1f9e9c8t)s Test Guidelines AUTHOR: Susan A.

DuPont de Nemours and Company Management: Carolyn S.

DuPont de Nemours and Company Management: Carolyn S.

AR226-3204 DuPont-2925 Supplement No. 1 TRADE SECRET Study Title H-24000: Biopersistence Screening 10-Dose Oral Gavage Study in Rats Supplement No. 1 Laboratory Project ID: DuPont-2925 AUTHOR: Carol Finlay, B.A.

AR226-3209 TRADE SECRET Study Title H-23926: Biopersistence Screening 10-Dose Oral Gavage Study in Rats Supplement No. 1 Laboratory Project ID: DuPont-2920 AUTHOR: Carol Finlay, B.A.

Amsterdam \ June : DuPont meets with Environment & Health Canada \ Nov. : DuPont presents at North America SETAC Meeting DuPont meets with U.S.

AlN No csi 000005 DuPont EMSE Report No. 13-03 PAGE RESERVED FOR SPECIFIC COUNTRY REQUIREMENTS EMSER13-03/4842 Page 20128 000006 DuPont EMSE Report No. 13-03 (CERTIFICATION OF AUTHENTICITY READY BIODEGRADATION OF 8-2 TELOMER B ALCOHOL (MODIFIED OECD 301D CLOSED BOTTLE TEST) We, the undersigned, declare that the work described in this report was performedunderour supervision, and that this report provides an accurate record of the procedures and results.

DuPont has ample toxicological and epidemiological data to support our confidence that the exposure guidelines established by DuPont are protective of human health.

3600 2551~i 2045 871 8370 2305 161 Note : Plasma samples analyzed by DuPont Haskell Global Centers for Health and Environmental Sciences results are rounded to nearest whole number DuPont Company Shimizu Works, Japan 2000 & 2008 PFOA Sample Results Worker Number 1 2 3 Average Mediani Minimuml Maximumi Standard Deviationi n= 2000* I Result (ppb) 1 57001 15001 30001 34001 30001 15001 57001 21281 31 2008 "* Result (ppb) 33201 1010 35001 26101 33201 10101 35001 13891 3 Notes: * 2000 results reflect whole blood measurements analyzed by National Medical Services - results rounded to nearest whole number . ** 2008 results reflect plasma samples analyzed by DuPont Haskell Global Centers for Health and Environmental Sciences - results rounded to nearest whole number .

DuPont has ample lexicological and epidemiological data to support our confidence that the exposure guidelines established by DuPont are protective of human health.

DuPont-4182 Company Sanitized.

APPENDICES DuPont-2932 LIST OF TABLES Page 1.

DuPont-2925 -7 Company Sanitized.

L du Pont de Nemours and Company -- `DuPont Haskell Laboratory P.O.

DPCahegacerelme4sbMer. 7A, u2e0r04 ATTACHMENT 1 TrrndVceeloohiasqrctespugsumoiesmnanesaictsceaietintnivdilototieatsniniingtnswloaatbeahtwEireeoceslPnooupAcmwiaaotr'rplisteplnirercrepecoWuhrtqvlieeaumeidndresasestceirtaiVvi.atltheyeisrNegfugrrioeoimlnefrltryaimeooateimtafnodhradryalttilthofcorsaetoPfhutemoectFdhvhOd.eefioiArnlsFcetof.suoeonpmroresmefematinaancttikhdisloleiiccvnnoaoindttfleoloupegaraccolgttosrheeyldmels,epefcooontlsfertatdaipnrlsoieudekcreCunpplmyroooomtsteedoenpusttahhcsonaeacvyfttoe.tDhhlledTeueocihPWncteoeufoednmsrtfmteodnarottseaison wFpgtyuroepoirdedwpeuoiluliclfnrtppieinorosfonsopveurrismodsevoeafiftudtihtloehedanisnrbtedhdeqaolpuotcuewuirsspm.teionPedsdnleieitnfcaupfasoltreeortmdondouabtthcteeitelo,ioonAhwn.og,waeasnencvndyeoritan,nbtthdehiaetntogiinfastvtuehobreiemdsAtirtgeotedefnduacnthytdeeawrmneawcpnytiti,tsnhDgD, uptuolPPeoamosnneattknfetooolttlhisofiuywsbeumdsiatthntehde General Guidelines for December 6 Submission This submission does not include the following types of documents: Draft documents where it is known that a final version exists RDtsoueobgtchmiuoeimntstaeuelndbOtmstfofiksiEcsneioPo)wAn-nd(nestooaeetdeblsietnpheeion,cuibtfghiechecsptrehoocasststis-oetconshxsebiiocceonkloleoowdgftyoEonaPdnAtedhteep(rehtmoiatxhirnimeceroaailcoftogthkhyeienasydeutqhbiuacmvsaiersrteseaiprlosroneroa)tdrsyacnobueEelPdnAnot, due iDnofocrummaetniotsn/ciomnpcreorvneinmgeenmtsission reduction efforts, treatment, recycle, and process Non-DuPont documents (includes documents from other companies, plaintiffs'counsel, etc.)